In the study, 10 postmenopausal women volunteers underwent a baseline evaluation then received twice-daily subcutaneous injections of 1 mg of GHRH for three months.

• 本项研究有10位停经后妇女志愿参与，先经过基线评估，再接受每日两次的GHRH皮下注射，持续3个月。